Industry snapshot
Key public data points
Historical & forecast
Base year 2025. Each series is official through its own latest government-data year (shown in the legend on each chart), and years beyond that are Claight estimates. As of July 2026 the current year is still in progress (2026 annual data is not yet published), so the forecast runs to 2030.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Industry Definition and Scope
What does the CBD Product Manufacturing in the US industry cover?
This industry involves the extraction and formulation of cannabidiol from federally compliant industrial hemp plants containing no more than the legally permitted thresholds of delta-9 tetrahydrocannabinol (THC) on a dry-weight basis. Manufacturers convert raw biomass or floral materials into bulk oils, distillates, or water-soluble powders, which are subsequently integrated into finished consumer goods. The scope spans across ingestibles like tinctures and capsules, as well as topical lotions and pet wellness products.
- •Primary processing centers on the extraction of cannabinoids from hemp flowers and leaves.
- •End-product segments include dietary supplements, cosmetics, and infused animal feed formulas.
- •Scope excludes recreational or medical cannabis manufacturing derived from high-THC marijuana plants.
Market Structure and Operators
Who operates in the industry and how is it structured?
The manufacturing landscape is characterized by a mix of specialized vertically integrated extraction companies and independent white-label or private-label contract manufacturers. Production is heavily reliant on domestic agricultural yields, which showed a significant concentration in high-value open-field cultivation. The market relies on specialized extraction facilities that must utilize food-grade or current Good Manufacturing Practice (cGMP) standards to secure commercial distribution contracts.
- •According to the USDA, U.S. floral hemp production grown in the open reached 33.2 million pounds in 2025.
- •The value of floral hemp grown in the open dominated the agricultural raw material base at $574 million in 2025.
- •Production is migrating toward protected environments, with the value of hemp produced under protection jumping to $93.3 million in 2025 to better control environmental variables.
Demand Drivers
What drives demand in the industry?
Consumer demand for manufactured CBD products is fundamentally driven by mainstream wellness trends, broader retail acceptance, and an expanding market for functional health ingredients. Consumer interest in non-intoxicating hemp derivatives for personal care, sleep aids, and holistic health continues to motivate retail product placement. Furthermore, technological developments in manufacturing, such as nanotechnology for increased bioavailability, stimulate product innovation and market penetration.
- •Expansion of regional and national retail pharmacy footprints carrying topical and cosmetic hemp products.
- •Rising consumer interest in specialized cannabinoid formulations targetting specific lifestyle requirements.
- •The expansion of specialized product categories such as grain and seed hemp, which saw its agricultural production value jump over 190% in 2025, signaling broader utilization.
Competitive Landscape and Notable Public Companies
Who are the notable companies in the industry?
Competition within the U.S. CBD manufacturing landscape is intense and highly distributed, featuring several specialized pure-play public operators alongside diversified multi-state cannabis corporations. Manufacturers compete on product purity, consistency, brand equity, and third-party lab verification (Certificates of Analysis). The market features well-known specialized brands as well as major Canadian corporations that have established U.S. infrastructure to capture market share.
- •Charlotte's Web Holdings, Inc. operates as one of the largest market share holders, utilizing a vertically integrated model.
- •cbdMD, Inc. focuses heavily on broad-spectrum and isolate formulations distributed via extensive e-commerce and retail networks.
- •Canopy Growth Corporation maintains a distinct strategic presence aimed at fast-tracking consumer product offerings within the United States.
- •Other prominent domestic and international public operators shaping the competitive landscape include Tilray Brands, Inc. and Cronos Group Inc.
Regulation and Compliance
How is the industry regulated?
The regulatory framework for CBD product manufacturing is evolving rapidly and remains a primary determinant of market access and corporate viability. While the Agriculture Improvement Act of 2018 initially legalized hemp-derived compounds, federal oversight has tightened considerably due to legislative interventions. Under Public Law 119-37 passed by Congress, stricter federal limits on total THC content are fundamentally shifting manufacturing parameters.
- •The Agriculture Improvement Act of 2018 established the federal framework for domestic hemp production and extraction.
- •Public Law 119-37 alters compliance by factoring total THC (including delta-8 and other variants) rather than just delta-9 THC.
- •New statutory requirements restrict hemp finished products from exceeding more than 0.4 milligrams of total THC per container.
- •The U.S. Food and Drug Administration (FDA) continues to advance its 'Cannabidiol Products Compliance and Enforcement Policy' to oversee the consumer marketplace.
Sources
Government, statistical and trade sources used for this Claight analysis.
- USDA National Agricultural Statistics Service National Hemp Report 2026 ·
- U.S. Congress Public Law 119-37 (2025) ·
- U.S. Food and Drug Administration (FDA) Regulatory Agenda 2026
Claight analysis of public industry data.